Two years of qualification
Audited Supplier
In This Store
Category:Active Pharmaceutical Ingredients > Other Active Pharmaceutical Ingredients
Product Name:Apalutamide
CAS No.:956104-40-8
Standard:ChP, USP, BP, EP, JP, In-house Standards, IP, Ph. Int
Price(USD):Negotiable
Company:Quanzhou Fortune Biopharma Co.,Ltd.
Grade: Pharmaceutical Grade
Factory Location: Quanzhou
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Sample Provided: no
Payment Terms: L/C
Apalutamide is a second-generation highly selective androgen receptor antagonist, and its affinity with androgen receptors is more than 5 times that of the first-generation androgen receptor antagonists. A phase III study involving 1207 patients with non-metastatic castration-resistant prostate cancer demonstrated that apalutamide significantly prolonged metastasis-free survival (40.5 vs 16.2 months) compared with placebo. 2018/2/14, Apalutamide was approved by the FDA for the treatment of non-metastatic (prostate cancer cells have not spread) castration-resistant prostate cancer (the disease still progresses after hormone therapy)
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094
Follow Us：
Pharma Sources Insight January 2025
